Reference
Ghanta V, et al. Life threatening rhabdomyolysis from the combination of ledipasvir/sofosbuvir and high dose statins. American Journal of Kidney Diseases 67: A48 abstr. 117, No. 5, May 2016. Available from: URL: http://doi.org/10.1053/j.ajkd.2016.03.124 [abstract] - USA
Rights and permissions
About this article
Cite this article
Atorvastatin/ledipasvir/sofosbuvir. Reactions Weekly 1609, 23 (2016). https://doi.org/10.1007/s40278-016-19319-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-016-19319-4